AU Stock MarketDetailed Quotes
1AIO Algorae Pharmaceuticals Ltd
- 0.002
- 0.0000.00%
20min DelayMarket Closed Nov 21 14:37 AET
3.37MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.002Pre Close0.00Turnover0.00552wk High0.00%Turnover Ratio1.69BShares0.00252wk Low--EPS TTM2.09MFloat Cap0.005Historical High0.00P/E (Static)1.05BShs Float0.002Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Algorae Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | -48.96%414.73K | -29.32%812.59K | 21.41%1.15M | 946.96K | ||
| Revenue from customers | ---- | ---- | -48.96%414.73K | -29.32%812.59K | 21.41%1.15M | --946.96K |
| Cash paid | 19.30%-1.63M | 17.85%-2.02M | -7.04%-2.46M | 47.52%-2.3M | -44.20%-4.38M | -3.04M |
| Payments to suppliers for goods and services | 19.30%-1.63M | 17.85%-2.02M | -7.04%-2.46M | 47.52%-2.3M | -44.20%-4.38M | ---3.04M |
| Direct interest received | 218.84%106.58K | 1,882.56%33.43K | -92.62%1.69K | -80.53%22.85K | 20.06%117.36K | --97.76K |
| Operating cash flow | 23.31%-1.52M | 2.74%-1.99M | -39.73%-2.04M | 53.00%-1.46M | -56.23%-3.11M | ---1.99M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -277.44K | -62.69%39.5K | -91.45%105.86K | 2,422.30%1.24M | -53.32K | |
| Net PPE purchase and sale | ---- | ---- | ---3.8K | ---- | 989.16%91.78K | ---10.32K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---42.99K |
| Net investment purchase and sale | ---277.44K | ---- | ---- | -90.77%105.86K | --1.15M | ---- |
| Net other investing changes | ---- | ---- | --43.3K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | ---277.44K | ---- | -62.69%39.5K | -91.45%105.86K | 2,422.30%1.24M | ---53.32K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | -71.73%523K | -60.52%1.85M | 10,621.72%4.69M | 11.35%-44.54K | -50.24K | |
| Net issuance payments of debt | ---- | ---- | --2.29M | ---- | ---- | ---- |
| Net common stock issuance | -73.37%572.26K | -24.76%2.15M | --2.86M | ---- | ---- | ---- |
| Net other financing activities | 83.53%-49.26K | 35.01%-299.07K | -933.31%-460.21K | 11.35%-44.54K | ---50.24K | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | -71.73%523K | -60.52%1.85M | 10,621.72%4.69M | 11.35%-44.54K | ---50.24K | ---- |
| Net cash flow | ||||||
| Beginning cash position | -50.73%2.09M | 170.18%4.24M | -47.08%1.57M | -39.59%2.96M | -28.47%4.91M | --6.86M |
| Current changes in cash | -839.18%-1.28M | -105.07%-136.05K | 291.64%2.68M | 27.14%-1.4M | 5.97%-1.92M | ---2.04M |
| Effect of exchange rate changes | -128.50%-2.36K | 161.57%8.27K | -415.53%-13.43K | 120.08%4.26K | -123.51%-21.19K | --90.14K |
| End cash Position | -80.34%808.41K | -3.01%4.11M | 170.18%4.24M | -47.08%1.57M | -39.59%2.96M | --4.91M |
| Free cash from | 23.31%-1.52M | 2.92%-1.99M | -39.99%-2.05M | 53.00%-1.46M | -52.15%-3.11M | ---2.04M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data